Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog)

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

November 1, 2025

Study Completion Date

August 1, 2027

Conditions
No Metastatic Breast Cancer
Interventions
OTHER

Face to face and telephonic interviews

"face to face interview : before the first chemotherapy treatment (M0), then at 3 months (M3), 6 months (M6) and 9 months (M9) after the first chemotherapy treatment.~Telephonic interview : every month between two face-to-face interviews, i.e. at 1 month after the first treatment (M1), at 2 months (M2), at 4 months (M4), at 5 months (M5), at 7 months (M7) and at 8 months (M8) after the first chemotherapy treatment."

Trial Locations (1)

54500

RECRUITING

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Institut de Cancérologie de Lorraine

OTHER